Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly Improved
01 sept. 2022 17h18 HE
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant...